Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32737316.
- Also identified by DOI 10.1038/s41467-020-17668-6 and PMC identifier 7395774.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Integrating results from genome-wide association studies (GWASs) and gene expression studies through transcriptome-wide association study (TWAS) has the potential to shed light on the causal molecular mechanisms underlying disease etiology. Here, we present a probabilistic Mendelian randomization (MR) method, PMR-Egger, for TWAS applications. PMR-Egger relies on a MR likelihood framework that unifies many existing TWAS and MR methods, accommodates multiple correlated instruments, tests the causal effect of gene on trait in the presence of horizontal pleiotropy, and is scalable to hundreds of thousands of individuals. In simulations, PMR-Egger provides calibrated type I error control for causal effect testing in the presence of horizontal pleiotropic effects, is reasonably robust under various types of model misspecifications, is more powerful than existing TWAS/MR approaches, and can directly test for horizontal pleiotropy. We illustrate the benefits of PMR-Egger in applications to 39 diseases and complex traits obtained from three GWASs including the UK Biobank.
Medical subject headings
- Genetic Pleiotropy
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Mendelian Randomization Analysis
- Models, Genetic
- Transcriptome